Meet The profesors
HomeEditionsAbout MTPAbout usContact
Breast CancerColorectal CancerGISTLung CancerNHL CancerProstate CancerRenal Cell Cancer
You are here: Home: Meet The Professors - Renal 1 | 2008: CME Information

Meet The Professors: A case-based discussion on the management of renal cell cancer in the adjuvant and metastatic settings

OVERVIEW OF ACTIVITY

An increased understanding of the biology of renal cell cancer (RCC), coupled with emerging clinical trial data, has resulted in the availability of several new therapeutic options for patients. Meet The Professors features relevant case-based discussions between community oncologists and clinical investigators to assist medical oncologists, hematologists and hematology-oncology fellows with the formulation of up-to-date management strategies for use in clinical practice.

LEARNING OBJECTIVES

  • Apply an understanding of the biology of clear cell RCC, including inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene and the pathway leading to VEGF overexpression, to therapeutic decision-making.
  • Develop a therapeutic algorithm that addresses the duration of treatment and sequential delivery of targeted biologic therapies and/or cytokines for patients with advanced RCC.
  • Communicate the role of cytoreductive nephrectomy to patients with RCC and known metastases.
  • Appraise emerging data on the safety and efficacy of combined targeted therapy for patients with RCC, and discern how these findings may impact current and future treatment algorithms.
  • Recognize the unique toxicities associated with novel systemic therapies for RCC, and recommend supportive measures to patients that may improve long-term tolerability.
  • Counsel appropriately selected patients with RCC about participation in ongoing clinical trials in the metastatic setting.

ACCREDITATION STATEMENT

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Research To Practice designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

HOW TO USE THIS CME ACTIVITY

This CME activity contains an audio component. To receive credit, the participant should review the CME information, listen to the CD and complete the Educational Assessment and Credit Form located on our website at ResearchToPractice.com/MTP/Renal.

This program is supported by educational grants from Bayer Pharmaceuticals Corporation/ Onyx Pharmaceuticals Inc, Genentech BioOncology and Pfizer Inc.

Table of Contents Top of Page